Insider Transactions Reported by 8 Insiders of Acurx Pharmaceuticals, Inc.

Symbol
ACXP on Nasdaq
Location
Staten Island, NY

Insiders trading volume in the past year

Acurx Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
DAVID P. LUCI President and CEO, Director, 10%+ Owner $1.16M +$50K +4.49% 05 Feb 2025
DELUCCIA ROBERT J Director, 10%+ Owner $1.03M +$50K +5.11% 05 Feb 2025
Carl Sailer Director $144K +$25K +21% 06 Jan 2025
Joseph C. Scodari Director $28.1K +$25K +800% 06 Jan 2025
JACK H. DEAN Director $28K +$10K +55.7% 06 Jan 2025
James J. Donohue Director $22.7K +$10K +78.8% 06 Jan 2025
Robert G. Shawah Chief Financial Officer 05 Feb 2025
THOMAS L. HARRISON Director 17 Jun 2024

Recent Insider Transactions by Companies or Individuals for Acurx Pharmaceuticals, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.